Obstructive sleep apnoea (OSA) is frequently associated with comorbidities that include
metabolic, cardiovascular, renal, pulmonary and neuropsychiatric. There is considerable …

Obstructive sleep apnea (OSA) is a highly prevalent disease, and is traditionally associated
with increased cardiovascular risk. The role of comorbidities in OSA patients has emerged …

Background: Noninvasive ventilation (NIV) is used for patients with chronic obstructive
pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical …

By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality.
Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco …

Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Age and smoking are common risk factors for COPD and other illnesses, often …

COPD and OSA are both highly prevalent, which implies that both disorders occurring
together (overlap syndrome) is likely to be common based on chance association alone …

Rationale: When obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease
(COPD) coexist in the so-called “overlap” syndrome, a high risk for mortality and morbidity …

Obstructive sleep apnea (OSA) is a highly prevalent disorder that has profound implications
on the outcomes of patients with chronic lung disease. The hallmark of OSA is a collapse of …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
and may frequently be complicated by sleep disorders. Insomnia and obstructive sleep …